151 related articles for article (PubMed ID: 30189238)
21. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
Nakane A; Gotoh Y; Ichihara J; Nagata H
Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
[TBL] [Abstract][Full Text] [Related]
22. Medicarpin isolated from Radix Hedysari ameliorates brain injury in a murine model of cerebral ischemia.
Chern CM; Lu CK; Liou KT; Wang YH; Tsai KC; Chang CL; Chang CC; Shen YC
J Food Drug Anal; 2021 Dec; 29(4):581-605. PubMed ID: 35649147
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
Blaya MO; Bramlett HM; Naidoo J; Pieper AA; Dietrich WD
J Neurotrauma; 2014 Mar; 31(5):476-86. PubMed ID: 24070637
[TBL] [Abstract][Full Text] [Related]
24. Silibinin ameliorates amylin-induced pancreatic β-cell apoptosis partly via upregulation of GLP-1R/PKA pathway.
Yang J; Sun Y; Xu F; Liu W; Mai Y; Hayashi T; Hattori S; Ushiki-Kaku Y; Onodera S; Tashiro SI; Ikejima T
Mol Cell Biochem; 2019 Feb; 452(1-2):83-94. PubMed ID: 30022448
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Exendin-4 on the differentiation of neural stem cells from subventricular zone of adult mice in vitro].
Zhao F; Xu HY; Ma K; Jiang JP; Zhang J; Dai C; Jin Y; Li P; Sun HT; Wang ZG; Chen XY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 May; 35(3):262-267. PubMed ID: 31257810
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
Bauman MD; Schumann CM; Carlson EL; Taylor SL; Vázquez-Rosa E; Cintrón-Pérez CJ; Shin MK; Williams NS; Pieper AA
Transl Psychiatry; 2018 Sep; 8(1):202. PubMed ID: 30258178
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
28. P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture.
Hill CS; Menon DK; Coleman MP
Neuroreport; 2018 Dec; 29(18):1544-1549. PubMed ID: 30334859
[TBL] [Abstract][Full Text] [Related]
29. P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury.
Yin TC; Britt JK; De Jesús-Cortés H; Lu Y; Genova RM; Khan MZ; Voorhees JR; Shao J; Katzman AC; Huntington PJ; Wassink C; McDaniel L; Newell EA; Dutca LM; Naidoo J; Cui H; Bassuk AG; Harper MM; McKnight SL; Ready JM; Pieper AA
Cell Rep; 2014 Sep; 8(6):1731-1740. PubMed ID: 25220467
[TBL] [Abstract][Full Text] [Related]
30. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.
Yang L; Yao D; Yang H; Wei Y; Peng Y; Ding Y; Shu L
Mol Endocrinol; 2016 Mar; 30(3):361-71. PubMed ID: 26789107
[TBL] [Abstract][Full Text] [Related]
31. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.
Walker AK; Rivera PD; Wang Q; Chuang JC; Tran S; Osborne-Lawrence S; Estill SJ; Starwalt R; Huntington P; Morlock L; Naidoo J; Williams NS; Ready JM; Eisch AJ; Pieper AA; Zigman JM
Mol Psychiatry; 2015 Apr; 20(4):500-8. PubMed ID: 24751964
[TBL] [Abstract][Full Text] [Related]
32. GABA requires GLP-1R to exert its pancreatic function during STZ challenge.
Shao W; Liu W; Liang P; Song Z; Israel O; Prud'homme GJ; Wang Q; Jin T
J Endocrinol; 2020 Sep; 246(3):207-222. PubMed ID: 32544878
[TBL] [Abstract][Full Text] [Related]
33. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
Jia Y; Gong N; Li TF; Zhu B; Wang YX
Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
[TBL] [Abstract][Full Text] [Related]
34. Geniposide improves repeated restraint stress-induced depression-like behavior in mice by ameliorating neuronal apoptosis via regulating GLP-1R/AKT signaling pathway.
Zhao Y; Li H; Fang F; Qin T; Xiao W; Wang Z; Ma S
Neurosci Lett; 2018 May; 676():19-26. PubMed ID: 29626654
[TBL] [Abstract][Full Text] [Related]
35. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
[TBL] [Abstract][Full Text] [Related]
36. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
37. The Small Molecule P7C3-A20 Exerts Neuroprotective Effects in a Hypoxic-ischemic Encephalopathy Model via Activation of PI3K/AKT/GSK3β Signaling.
Bai J; Zeng S; Zhu J; Fu C; He M; Zhu J; Chen S; Fu X; Li P; Lin Z
Neuroscience; 2020 Aug; 441():197-208. PubMed ID: 32504794
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
Koehler JA; Kain T; Drucker DJ
Endocrinology; 2011 Sep; 152(9):3362-72. PubMed ID: 21771884
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
Redij T; Ma J; Li Z; Hua X; Li Z
J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
[TBL] [Abstract][Full Text] [Related]
40. Claulansine F promoted the neuronal differentiation of neural stem and progenitor cells through Akt/GSK-3β/β-catenin pathway.
Huang JY; Ma YZ; Yuan YH; Zuo W; Chu SF; Liu H; Du GH; Zhang DM; Chen NH
Eur J Pharmacol; 2016 Sep; 786():72-84. PubMed ID: 27179990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
